{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:32:30Z","timestamp":1773268350229,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia & Lymphoma Society","doi-asserted-by":"crossref","award":["2400-13"],"award-info":[{"award-number":["2400-13"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gatorade Trust"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.leukres.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T15:08:02Z","timestamp":1461942482000},"page":"69-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A new model to predict remission status in AML patients based on day 14 bone marrow biopsy"],"prefix":"10.1016","volume":"46","author":[{"given":"Maxim","family":"Norkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Leather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmikanth","family":"Katragadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan S.","family":"Moreb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Stratford","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack W.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Hiemenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Wingard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Cogle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2016.04.013_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood-2002-02-0532","article-title":"Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 trial","volume":"101","author":"Kern","year":"2003","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.leukres.2016.04.013_bib0010","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1002\/cncr.25263","article-title":"Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group","volume":"116","author":"Rowe","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2016.04.013_bib0015","unstructured":"National Comprehensive Cancer Network, Acute Myeloid Leukemia, http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf accessed February 6, 201. (Version 2.2014)."},{"issue":"3","key":"10.1016\/j.leukres.2016.04.013_bib0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2016.04.013_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOH.0b013e32835d8207","article-title":"New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemia","volume":"20","author":"Mattison","year":"2013","journal-title":"Curr. Opin. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2016.04.013_bib0030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.21133","article-title":"Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia","volume":"83","author":"Hussein","year":"2008","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2016.04.013_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.leukres.2012.09.016","article-title":"Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia","volume":"37","author":"Morris","year":"2013","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.leukres.2016.04.013_bib0040","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3324\/haematol.12825","article-title":"Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia","volume":"93","author":"Yanada","year":"2008","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.leukres.2016.04.013_bib0045","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2016.04.013_bib0050","first-page":"1285","article-title":"Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia","volume":"85","author":"Liso","year":"2000","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.leukres.2016.04.013_bib0055","first-page":"3605","article-title":"Outcomes and prognostic factors following double-induction chemotherapy in AML - a large, single institutional experience","volume":"118","author":"Lancet","year":"2011","journal-title":"ASH Annual Meeting Abstracts"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T11:00:50Z","timestamp":1582542050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616300613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":11,"alternative-id":["S0145212616300613"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.04.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new model to predict remission status in AML patients based on day 14 bone marrow biopsy","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}